In our Danville, Virginia facility, Luna has assembled an extraordinarily talented business and technical team with decades of development, commercialization and manufacturing expertise. Additionally, the company is supported by a scientific advisory board consisting of recognized experts in the field of nanotechnology and nanomaterials, including Dr. Harold Kroto on the team of scientists who achieved the Nobel prize in the discovery of the Buckminster fullerene, or "buckyball".

Robert P. Lenk, Ph.D., President, nanoWorks Division - Dr. Lenk is the founder of three companies, has been involved with two initial public offerings, and is experienced in bringing new pharmaceuticals to market. He has served as President of Oncovector Inc., a biopharmaceutical company and is also a former President and Chief Executive Officer of Therapeutics 2000, an inhalation pharmaceutical research company. Dr. Lenk holds a doctorate in Cell Biology from the Massachusetts Institute of Technology.

Kenneth L. Walker, Ph.D., Executive Vice President, nanoWorks Division - Dr. Walker is a founder and former President of Specialty Photonic Devices, a business unit of OFS Fitel which focused on the development of proprietary materials and which was purchased from Lucent Technologies, Inc. He is also a former head of optical fiber research at Bell Laboratories. Dr. Walker received a bachelor's degree from the California Institute of Technology and a doctorate from Stanford University. He is a member of the National Academy of Engineering and holds more than 50 patents.

Charles B. Gause, Senior Vice President, Business Development, Luna Innovations - Mr. Gause is an instrumental part of the team that made the Luna nanoWorks division a reality. He established the operations, business development, and manufacturing processes for the Danville-based nanomaterials facility. With an extensive manufacturing and engineering science background, Mr. Gause works to identify and develop technologies into market opportunities based upon Luna's nanotechnologies. Mr. Gause is active in nanotechnology policy initiatives such as the NanoHealth Enterprise Initiative and serves on the Northern Virginia's Technology Council's Nanotechnology Committee and Virginia's Joint Commission on Technology and Science (JCOTS) Nanotechnology Advisory Committee. Mr. Gause received his engineering degree from the University of North Carolina, Charlotte.

Chris Kepley, Ph.D., MBA, nanoImmunology Group Leader, nanoWorks Division – Dr. Kepley was previously Assistant Professor with the Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology at the Virginia Commonwealth University (VCU) School of Medicine. For almost 20 years, Dr. Kepley has devoted his research to studying the mechanisms of allergic disease — the sixth leading cause of chronic disease in the U.S. Dr. Kepley was the first U.S. recipient of the Henning Lowenstein Research Award, given annually to a scientist under the age of 40 for excellence in allergy research. Dr. Kepley received his doctorate in Philosophy, Microbiology & Immunology from the Medical College of Virginia, and his master's degree in Business Administration from the College of William & Mary.

Steven M. Joslin, Ph.D., Director of Manufacturing, nanoWorks Division - Dr. Joslin is a former Engineering Manager at MEMC Electronic Materials, Inc., where he was responsible for technology transfer, development, and continuous improvement of Cz growth processes. Dr. Joslin received his undergraduate, master's and doctorate from the University of Tennessee. He holds two patents.